US FDA is investigating the possible increased risk of death from use of paclitaxel-coated balloons and stents to treat peripheral artery disease (PAD), but the agency says benefits continue to outweigh the risks of approved devices.
FDA disclosed its ongoing analysis of the issue in a Jan. 17 letter to health-care providers. It cites a...






